Coherus Positive And Up For The Fight Amid Amneal Pegfilgrastim Deals
Full Suite Of Products Boosted By Coherus’ Efforts To Defend Pre-Filled Syringe Market
Coherus BioSciences feels its bearing and clout in the US pegfilgrastim market will stand it in good stead as other players scrabble to compete on the more lucrative formulations of Amgen’s Neulasta.
